Viridian Therapeutics, Inc. (VRDN)
NASDAQ
Market Cap
$785.65M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
49 of 809
Rank in Industry
41 of 445
Largest Insider Buys in Sector
VRDN Stock Price History Chart
VRDN Stock Performance
About Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.
Insider Activity of Viridian Therapeutics, Inc.
Over the last 12 months, insiders at Viridian Therapeutics, Inc. have bought $10M and sold $0 worth of Viridian Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Viridian Therapeutics, Inc. have bought $9.25M and sold $4.43M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Fairmount Funds Management LLC (See Remarks) — $10M.
The last purchase of 476,190 shares for transaction amount of $10M was made by Fairmount Funds Management LLC (See Remarks) on 2024‑01‑22.
List of Insider Buy and Sell Transactions, Viridian Therapeutics, Inc.
| 2024-01-22 | Fairmount Funds Management LLC | See Remarks | 476,190 0.9578% | $21.00 | $10M | -17.99% | ||
| 2023-06-16 | Sale | Meisner Lara | Chief Legal Officer | 27 <0.0001% | $28.35 | $765 | -34.59% | |
| 2023-06-15 | Sale | Meisner Lara | Chief Legal Officer | 2,269 0.0054% | $28.02 | $63,577 | -36.35% | |
| 2023-06-06 | Sale | Meisner Lara | Chief Legal Officer | 5,126 0.0121% | $25.02 | $128,253 | -28.09% | |
| 2023-06-05 | Sale | Meisner Lara | Chief Legal Officer | 499 0.0012% | $25.03 | $12,490 | -27.66% | |
| 2023-06-02 | Sale | Meisner Lara | Chief Legal Officer | 1,875 0.0044% | $24.21 | $45,394 | -25.76% | |
| 2023-04-12 | Myers Scott Dunseth | Chief Executive Officer | 4,000 0.01% | $25.37 | $101,479 | -24.08% | ||
| 2023-03-13 | Myers Scott Dunseth | 5,500 0.0137% | $29.15 | $160,324 | -32.03% | |||
| 2023-03-09 | Sale | Meisner Lara | General Counsel and Secretary | 29,971 0.0733% | $29.07 | $871,257 | -33.06% | |
| 2023-02-02 | Sale | Violin Jonathan | Chief Executive Officer | 50,000 0.1224% | $36.80 | $1.84M | -41.26% | |
| 2023-01-23 | Sale | Meisner Lara | General Counsel and Secretary | 6,843 0.0169% | $35.66 | $244,021 | -37.48% | |
| 2023-01-17 | Sale | Katz Barrett | Chief Medical Officer | 24,853 0.0607% | $37.21 | $924,780 | -40.03% | |
| 2023-01-10 | Sale | Katz Barrett | Chief Medical Officer | 47,377 0.1162% | $35.30 | $1.67M | -35.46% | |
| 2022-12-21 | Sale | Meisner Lara | General Counsel and Secretary | 16,326 0.0503% | $29.19 | $476,556 | -19.58% | |
| 2022-12-16 | Sale | Meisner Lara | General Counsel and Secretary | 1,297 0.0041% | $28.44 | $36,887 | -14.53% | |
| 2022-12-14 | Sale | Meisner Lara | General Counsel and Secretary | 15,656 0.0491% | $28.12 | $440,247 | -14.43% | |
| 2022-11-15 | Sale | Meisner Lara | General Counsel and Secretary | 8,125 0.0244% | $22.05 | $179,156 | +8.62% | |
| 2022-08-17 | Fairmount Healthcare Fund II L.P. | 425,531 1.301% | $23.50 | $10M | +8.93% | |||
| 2022-06-01 | Sale | Violin Jonathan | Chief Executive Officer | 30,000 0.1086% | $12.20 | $366,000 | +95.88% | |
| 2022-05-02 | Sale | Violin Jonathan | Chief Executive Officer | 30,000 0.1091% | $13.04 | $391,200 | +75.00% |
Insider Historical Profitability
0.95%
| Fairmount Funds Management LLC | See Remarks | 1839954 3.4989% | $12.31 | 2 | 0 | +43.22% |
| Frazier Life Sciences Public Fund, L.P. | 10 percent owner | 1505200 2.8624% | $12.31 | 1 | 0 | +25.75% |
| Fairmount Healthcare Fund II L.P. | 1363764 2.5934% | $12.31 | 1 | 0 | +8.93% | |
| Booth Bruce | director | 1351090 2.5693% | $12.31 | 1 | 0 | +6.91% |
| Logos Global Master Fund LP | 10 percent owner | 550000 1.0459% | $12.31 | 2 | 0 | +5.96% |
| Violin Jonathan | Chief Executive Officer | 480905 0.9145% | $12.31 | 0 | 9 | |
| LEFKOFF KYLE | director | 463473 0.8814% | $12.31 | 0 | 9 | |
| Riccitelli Samuel D | President & CEO | 345130 0.6563% | $12.31 | 2 | 0 | |
| Myers Scott Dunseth | Chief Executive Officer | 259500 0.4935% | $12.31 | 2 | 0 | <0.0001% |
| Meisner Lara | Chief Legal Officer | 29971 0.057% | $12.31 | 0 | 11 | |
| Hughes Thomas E. | director | 12827 0.0244% | $12.31 | 1 | 1 | <0.0001% |
| Levy Adam Scott | Chief Business Officer | 10540 0.02% | $12.31 | 2 | 0 | +4.18% |
| Katz Barrett | Chief Medical Officer | 0 0% | $12.31 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Fidelity Investments | $164.86M | 14.75 | 9.42M | +23.47% | +$31.34M | 0.01 | |
| Paradigm BioCapital Advisors LP | $88.1M | 7.88 | 5.03M | +4.94% | +$4.15M | 3.2 | |
| State Street | $78.6M | 7.03 | 4.49M | +65.73% | +$31.17M | <0.01 | |
| Vr Adviser Llc | $67.99M | 6.08 | 3.88M | +<0.01% | +$840.48 | 3.3 | |
| BlackRock | $66.76M | 5.97 | 3.81M | +11.27% | +$6.76M | <0.01 | |
| Perceptive Advisors | $64.04M | 5.73 | 3.66M | +111.37% | +$33.74M | 0.04 | |
| Deep Track Capital Lp | $60.52M | 5.42 | 3.46M | -4.84% | -$3.08M | 0.28 | |
| The Vanguard Group | $56.63M | 5.07 | 3.23M | +7.78% | +$4.09M | <0.01 | |
| Maverick Capital Ltd | $47.14M | 4.22 | 2.69M | +15.76% | +$6.42M | 0.92 | |
| Commodore Capital, LP | $33.88M | 3.03 | 1.93M | +0.55% | +$185,238.29 | 2.39 | |
| Fairmount Funds Management LLC | $32.32M | 2.89 | 1.85M | +34.77% | +$8.34M | 3.52 | |
| AllianceBernstein | $30.17M | 2.7 | 1.72M | -16.35% | -$5.89M | 0.01 | |
| Vivo Capital | $29.39M | 2.63 | 1.68M | 0% | +$0 | 2.59 | |
| Great Point Partners | $23.38M | 2.09 | 1.33M | New | +$23.38M | 3.92 | |
| Nuveen | $23.33M | 2.09 | 1.33M | +469.72% | +$19.24M | 0.01 | |
| Geode Capital Management | $20.39M | 1.82 | 1.16M | +17.07% | +$2.97M | <0.01 | |
| Novo Holdings A/S | $19.26M | 1.72 | 1.1M | New | +$19.26M | 1.35 | |
| Yiheng Capital Llc | $16.6M | 1.49 | 948,130 | -22.82% | -$4.91M | 2.42 | |
| Polar Capital | $15.57M | 1.39 | 889,198 | -9.26% | -$1.59M | 0.09 | |
| Citadel Advisors LLC | $13.35M | 1.2 | 762,411 | -14.01% | -$2.18M | 0.01 | |
| 5Am Venture Management Llc | $12.9M | 1.15 | 736,595 | +25.57% | +$2.63M | 0.87 | |
| Logos Global Management Lp | $12.26M | 1.1 | 700,000 | +16.67% | +$1.75M | 1.32 | |
| Tang Capital Management, LLC | $12.13M | 1.09 | 692,925 | 0% | +$0 | 0.05 | |
| GHOST TREE CAPITAL LLC | $10.94M | 0.98 | 625,000 | +108.33% | +$5.69M | 3.56 | |
| Octagon Capital Advisors LP | $10.86M | 0.97 | 620,000 | 0% | +$0 | 1.42 | |
| Bioimpact Capital Llc | $10.75M | 0.96 | 614,010 | +514.01% | +$9M | 1.74 | |
| RTW Investments, LP | $10.61M | 0.95 | 605,816 | 0% | +$0 | 0.16 | |
| Morgan Stanley | $9.85M | 0.88 | 562,541 | +7.17% | +$659,076.47 | <0.01 | |
| Goldman Sachs | $9.51M | 0.85 | 543,140 | +42.28% | +$2.83M | <0.01 | |
| Bank of America | $8.33M | 0.75 | 475,733 | +66.08% | +$3.31M | <0.01 | |
| Northern Trust | $8.1M | 0.73 | 462,680 | +11.86% | +$858,672.81 | <0.01 | |
| Woodline Partners LP | $7.69M | 0.69 | 438,922 | New | +$7.69M | 0.07 | |
| HERITAGE ASSET MANAGEMENT INC | $7.57M | 0.69 | 438,767 | -3.21% | -$250,977.65 | 0.04 | |
| Charles Schwab | $7.43M | 0.66 | 424,085 | +14.21% | +$924,072.70 | <0.01 | |
| Rafferty Asset Management Llc | $7.16M | 0.64 | 408,887 | +101.93% | +$3.61M | 0.02 | |
| Fisher Asset Management Llc | $6.81M | 0.61 | 389,087 | New | +$6.81M | <0.01 | |
| UBS | $6.65M | 0.6 | 379,584 | +164.73% | +$4.14M | <0.01 | |
| Citigroup | $6.09M | 0.55 | 347,913 | +312.77% | +$4.62M | 0.01 | |
| Soleus Capital Management, L.P. | $5.95M | 0.53 | 340,000 | +146.38% | +$3.54M | 0.06 | |
| Russell Investments Group Ltd | $5.63M | 0.5 | 321,606 | -2.39% | -$137,943.95 | 0.01 | |
| Two Sigma Advisers LP | $5.33M | 0.48 | 304,400 | +203.49% | +$3.57M | 0.01 | |
| Candriam S C A | $4.9M | 0.44 | 280,000 | New | +$4.9M | 0.03 | |
| Renaissance Technologies | $4.58M | 0.41 | 261,700 | +1,852.98% | +$4.35M | 0.01 | |
| Wellington Management Company | $4.22M | 0.38 | 240,829 | +25.37% | +$853,297.36 | <0.01 | |
| Two Sigma | $3.97M | 0.36 | 226,854 | New | +$3.97M | 0.01 | |
| ACUTA CAPITAL PARTNERS LLC | $3.49M | 0.31 | 199,433 | -29.15% | -$1.44M | 2.27 | |
| HighVista Strategies | $3.48M | 0.31 | 198,484 | 0% | +$0 | 1.28 | |
| Schonfeld Group | $2.87M | 0.26 | 164,013 | -8.33% | -$261,004.00 | 0.02 | |
| BNY Mellon | $2.66M | 0.24 | 151,862 | +1.37% | +$35,912.92 | <0.01 | |
| Eversept Partners LP | $2.49M | 0.22 | 142,075 | +3.44% | +$82,857.31 | 0.19 |